Cargando…

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells

RUNX2 is a transcription factor that participates in osteoblast differentiation and chondrocyte maturation and plays an important role in the invasion and metastasis of cancers. With the deepening of research, evidence has indicated the correlation between RUNX2 and bone destruction in cancers. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Beihui, Liu, Huixin, Chan, Szehoi, Liu, Junru, Gu, Jingli, Chen, Meilan, Kuang, Lifen, Li, Xiaozhe, Zhang, Xingding, Li, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006269/ https://www.ncbi.nlm.nih.gov/pubmed/36897488 http://dx.doi.org/10.1007/s12032-023-01960-8

Ejemplares similares

Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study
por: Xiaozhe, Li, et al.
Publicado: (2022)

Health‐related quality of life of patients with multiple myeloma: A real‐world study in China
por: Li, Xiaozhe, et al.
Publicado: (2020)

Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT
por: Sun, Qian, et al.
Publicado: (2022)

Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
por: Gu, Jingli, et al.
Publicado: (2021)

Comparison of efficacy, safety, patients’ quality of life, and doctors’ occupational stress between lenalidomide‐based and bortezomib‐based induction in patients with newly diagnosed multiple myeloma
por: Xu, Limei, et al.
Publicado: (2021)

Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score
por: Chen, Yadong, et al.
Publicado: (2023)

Oscillating Fluid Flow Activated Osteocyte Lysate‐Based Hydrogel for Regulating Osteoblast/Osteoclast Homeostasis to Enhance Bone Repair
por: Zheng, Liyuan, et al.
Publicado: (2023)

1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China
por: Li, Xiaozhe, et al.
Publicado: (2019)

Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance
por: Liu, Junru, et al.
Publicado: (2023)

Investigation of the optimal duration of bed rest in the supine position to reduce complications after lumbar puncture combined with intrathecal chemotherapy: a multicenter prospective randomized controlled trial
por: Li, Juan, et al.
Publicado: (2018)

Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing
por: Zhang, Bingqing, et al.
Publicado: (2019)

Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma
por: Li, Ying, et al.
Publicado: (2016)

Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
por: Diao, Xiangwen, et al.
Publicado: (2017)

Bortezomib followed by autologous stem cell transplantation in a patient with rheumatoid arthritis: A case report and review of the literature
por: Liu, Junru, et al.
Publicado: (2016)

Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)

Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation
por: Sekiguchi, Yuusuke, et al.
Publicado: (2017)

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
por: Faict, Sylvia, et al.
Publicado: (2018)

Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts
por: Qiao, Minna, et al.
Publicado: (2015)

Effect of zinc substitution in hydroxyapatite coating on osteoblast and osteoclast differentiation under osteoblast/osteoclast co-culture
por: Meng, Guolong, et al.
Publicado: (2019)

Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma
por: Mansour, Anna, et al.
Publicado: (2017)

Osteoblast-Osteoclast Communication and Bone Homeostasis
por: Kim, Jung-Min, et al.
Publicado: (2020)

Runx2 is essential for the transdifferentiation of chondrocytes into osteoblasts
por: Qin, Xin, et al.
Publicado: (2020)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
por: Adamik, Juraj, et al.
Publicado: (2019)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
por: Gai, Dongzheng, et al.
Publicado: (2022)

Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer
por: Kong, Depei, et al.
Publicado: (2023)

Myeloma cells suppress osteoblasts through sclerostin secretion
por: Colucci, S, et al.
Publicado: (2011)

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2
por: Komori, Toshihisa
Publicado: (2019)

Primary mouse osteoblast and osteoclast culturing and analysis
por: Chevalier, Claire, et al.
Publicado: (2021)

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation
por: Wei, Rongfang, et al.
Publicado: (2023)

Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase
por: Ling, Min, et al.
Publicado: (2017)

Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast–Osteoblasts Communication in Bone Remodeling
por: Yuan, Feng-Lai, et al.
Publicado: (2018)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells
por: Geng, Yuan-Ming, et al.
Publicado: (2019)

CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation
por: Li, Xueni, et al.
Publicado: (2008)

Cyclophilin A Promotes Osteoblast Differentiation by Regulating Runx2
por: Piao, Meiyu, et al.
Publicado: (2022)

Akt1 in Osteoblasts and Osteoclasts Controls Bone Remodeling
por: Kawamura, Naohiro, et al.
Publicado: (2007)

Osteoclastic bone resorption directly activates osteoblast function
por: Udagawa, Nobuyuki
Publicado: (2012)

Potential of Resveratrol Analogues as Antagonists of Osteoclasts and Promoters of Osteoblasts
por: Kupisiewicz, Katarzyna, et al.
Publicado: (2010)

Commensal Microbiota Enhance Both Osteoclast and Osteoblast Activities
por: Uchida, Yoko, et al.
Publicado: (2018)

Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes
por: Rathinavelu, Selvalakshmi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3gfgt81o5hk5gkd8n56s9sl085